Lupus (SLE): vizsgálatok itt: Egyesült Államok
100 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Where
- Ann Arbor, Atlanta, Chicago, Dallas, Gainesville, Houston, Little Rock, Miami, New Orleans, New York, Plantation, Stony Brook, Summit, Syracuse, Tampa, Tustin, Worcester
- Életkor
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- Nkarta, Inc.
See details and how to joinNCT06557265 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- Where
- Clearwater, Irving, La Palma, Orlando, San Antonio, Syracuse
- Életkor
- 18 év to 70 év
- People
- 148 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06625671 - 1. fázisTaking peopleA Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Where
- Beverly Hills, Cleveland, Durham, Fullerton, Gainesville, Irvine, Los Angeles, Louisville, Memphis, Miami, Minneapolis, New York, Oklahoma City, Omaha, Philadelphia, San Francisco
- Életkor
- 12 év to 70 év
- People
- 244 worldwide
- Run by
- Fate Therapeutics
See details and how to joinNCT06308978 - 1/2. fázisCsak meghívásosElectromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
- Where
- New York
- People
- 120
- Run by
- Truway Health, Inc.
See details and how to joinNCT07221565 - 2. fázisTaking people2-HOBA in Systemic Lupus Erythematosus
- Where
- Nashville
- Életkor
- 18 év and over
- People
- 42
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT07225543 - No phaseTaking peoplePredictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- Where
- Baltimore, Chicago, New York, Oklahoma City, Salt Lake City
- Életkor
- 18 év to 45 év
- People
- 700 worldwide
- Run by
- Hospital for Special Surgery, New York
See details and how to joinNCT00198068 - 1. fázisTaking peopleAlnuctamab for Refractory SLE (LATTE Study)
- Where
- New York
- Életkor
- 18 év to 60 év
- People
- 21
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07219563 - No phaseTaking peopleLupus Landmark Study: A Prospective Registry and Biorepository
- Where
- Atlanta, Beverly Hills, Birmingham, Boston, Chapel Hill, Chicago, Cleveland, Dallas, Los Angeles, Manhasset, Miami, Nashville, New York, St Louis, Syracuse, Tucson, Washington D.C., Worcester
- Életkor
- 18 év to 110 év
- People
- 3500 worldwide
- Run by
- Lupus Research Alliance
See details and how to joinNCT05934149 - 1. fázisTaking peopleA Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
- Where
- Allen, San Antonio
- Életkor
- 18 év to 65 év
- People
- 30 worldwide
- Run by
- Climb Bio, Inc.
See details and how to joinNCT07011043 - 1. fázisCsak meghívásosA Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
- Where
- Buffalo, Redwood City
- Életkor
- 18 év to 80 év
- People
- 180
- Run by
- Adicet Therapeutics
See details and how to joinNCT06375993 - No phaseTaking peopleRheumatology Patient Registry and Biorepository
- Where
- New Haven
- Életkor
- 18 év to 99 év
- People
- 5000
- Run by
- Yale University
See details and how to joinNCT04402086 - 2/3. fázisTaking peopleA Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- Where
- Denver
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Kyverna Therapeutics
See details and how to joinNCT07403188 · EU 2024-511198-31-00 - No phaseTaking peopleCorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
- Where
- Waltham
- Életkor
- 18 év and over
- People
- 1000
- Run by
- CorEvitas
See details and how to joinNCT06804057 - No phaseTaking peopleResearch Accelerated by You Lupus Registry
- Where
- Washington D.C.
- People
- 10 000
- Run by
- Lupus Foundation of America
See details and how to joinNCT06927219 - No phaseTaking peopleDuke Lupus Registry
- Where
- Durham
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Duke University
See details and how to joinNCT00512694 - No phaseTaking peopleMaternal Autoimmune Disease Research Alliance (MADRA) Registry
- Where
- Durham
- People
- 1000
- Run by
- Duke University
See details and how to joinNCT03276923 - No phaseTaking peopleHelping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
- Where
- Salt Lake City
- Életkor
- 18 év to 65 év
- People
- 30
- Run by
- University of Utah
See details and how to joinNCT07282392 - 1. fázisTaking peopleREACT-01: Reversing Autoimmunity Through Cell Therapy
- Where
- Seattle
- Életkor
- 2 év to 30 év
- People
- 12
- Run by
- Seattle Children's Hospital
See details and how to joinNCT06465147 - Korai 1. fázisTaking peopleSafety and Efficacy of ONT01 in Lupus
- Where
- New York
- Életkor
- 18 év and over
- People
- 61
- Run by
- Hospital for Special Surgery, New York
See details and how to joinNCT07107659 - 4. fázisTaking peopleSafety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- Where
- Atlanta, Columbus, Fort Worth, Glendale, Lawrenceville, Oklahoma City
- Életkor
- 18 év to 80 év
- People
- 30
- Run by
- NephroNet, Inc.
See details and how to joinNCT07225387 - 1. fázisTaking peopleUC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
- Where
- Charleston
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- LiveKidney.Bio
See details and how to joinNCT06737380 - 1. fázisTaking peopleBAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
- Where
- Columbus
- Életkor
- 18 év to 65 év
- People
- 18
- Run by
- Luminary Therapeutics
See details and how to joinNCT06340750 - No phaseTaking peopleRepository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- Where
- New York
- Életkor
- 18 év and over
- People
- 2000
- Run by
- The Rogosin Institute
See details and how to joinNCT01802034 - 1. fázisTaking peopleOpen-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
- Where
- Plantation
- Életkor
- 18 év and over
- People
- 30
- Run by
- IRIS Research and Development, LLC
See details and how to joinNCT06581562 - 1/2. fázisTaking peopleEarly Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
- Where
- Palo Alto
- Életkor
- 1 év to 30 év
- People
- 12
- Run by
- Alice Bertaina
See details and how to joinNCT05508009